Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major
Related Experiment Video
Updated: Jun 22, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
1MRI Laboratory, Institute of Clinical Physiology, CNR, and Gabriele Monasterio Foundation, Via Moruzzi 1, 56124 Pisa, Italy. alessia.pepe@ifc.cnr.it
Insights
Myocardial fibrosis is present in 24% of thalassaemia major patients, increasing with age. Electrocardiogram (ECG) changes accurately predict this scarring, highlighting its link to cardiac complications.
Area of Science:
- Cardiology
- Radiology
- Hematology
Background:
- Cardiovascular magnetic resonance (CMR) with delayed enhancement (DE) visualizes myocardial scarring.
- No prior studies specifically investigated DE CMR in thalassaemia major patients.
Purpose of the Study:
- To determine the prevalence and extent of myocardial fibrosis/necrosis using DE CMR in thalassaemia major.
- To identify clinical and instrumental factors associated with myocardial scarring in this population.
Main Methods:
- 115 thalassaemia major patients underwent DE CMR for scarring quantification.
- Myocardial iron overload was assessed using T2* imaging.
- Biventricular function was evaluated via cine imaging.
Main Results:
- 24% of patients (28/115) showed DE, indicating myocardial scarring.
- Scarring extent averaged 3.9%.
- DE was more prevalent in older patients and correlated significantly with ECG abnormalities, but not with iron levels or biventricular function.
Conclusions:
- Myocardial fibrosis/necrosis is a significant, age-dependent finding in thalassaemia major.
- ECG changes are accurate predictors of myocardial scarring.
- This scarring correlates with cardiovascular risk factors and complications.
Background:
Cardiovascular magnetic resonance (CMR) by delayed enhancement (DE) enables visualisation of myocardial scarring, but no dedicated studies are available in thalassaemia major.
Objective:
To investigate the prevalence, extent, clinical and instrumental correlates of myocardial fibrosis or necrosis by DE CMR in patients with thalassaemia major.
Patients:
115 Patients with thalassaemia major consecutively examined at an MRI laboratory.
Methods:
DE images were acquired to quantify myocardial scarring. Myocardial iron overload was determined by multislice multiecho T2*. Cine images were obtained to evaluate biventricular function.
Results:
DE areas were present in 28/115 patients (24%). The mean (SD) extent of DE was 3.9 (2.4)%. In 26 patients the location of fibrosis was not specific and patchy distribution was prevalent. Two patients showed transmural DE following coronary distribution. The DE group was significantly older than the no-DE group (31 (7.7) years vs 26 (7.7) years, p = 0.004). No significant relation with heart T2* values and biventricular function was found. A significant correlation was found between the presence of DE and changes in ECG (ECG abnormal in the DE group 22/28 patients and in the no-DE group 30/87 patients; chi(2) = 14.9; p<0.001).
Conclusions:
In patients with thalassaemia the significant presence of myocardial fibrosis/necrosis seems to be a time-dependent process correlating with cardiovascular risk factors and cardiac complications. Levels of HCV antibodies are significantly higher in the serum of patients with thalassaemia with myocardial fibrosis/necrosis. ECG changes showed a good accuracy in predicting myocardial scarring.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System V: CT
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies